Brief: Inhalation Sciences Sweden Q1 Operating Loss At SEK 4.1 Million
May 16 (Reuters) - INHALATION SCIENCES SWEDEN AB ISAB.TE :
* Q1 NET SALES SEK 259,000 VERSUS SEK 8.0 MLN IN JAN-DEC
2017
* Q1 OPERATING LOSS SEK 4.1 MILLION VERSUS LOSS SEK 6.6 MLN
IN
JAN-DEC 2017
Source text for Eikon: ID:nWkr9Qp11x
Further company coverage: ISAB.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna